APPLICATION
ANDA071404
TYPE
ANDA
ORIGINAL APPROVAL
1987-04-21
LATEST ACTION
2008-01-04
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
LORAZEPAMPrescription
LORAZEPAM 1MG · TABLET · ORAL
Approval history
2008-01-04Labeling · Supplement 34AP
2005-06-15Labeling · Supplement 24AP
1993-03-31Labeling · Supplement 14AP
1988-10-14Labeling · Supplement 5AP
1987-04-21OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.